Cited by 660Chronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseasesSmoking Behavior and Cessation

The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.

Complex chronic comorbidities of COPD

Open access

Fabbri, L. M., Luppi, F., Beghé, B., Rabe, K. F.·2008·European Respiratory Journal

DOI 10.1183/09031936.00114307

Open this paper in CoChat — free account

Abstract

Chronic obstructive pulmonary disease (COPD) is defined by fixed airflow limitation associated with an abnormal pulmonary and systemic inflammatory response of the lungs to cigarette smoke. The systemic inflammation induced by smoking may also cause chronic heart failure, metabolic syndrome and other chronic diseases, which may contribute to the clinical manifestations and natural history of COPD. Thus COPD can no longer be considered a disease only of the lungs, as it is often associated with a wide variety of systemic consequences. A better understanding of the origin and consequences of systemic inflammation, and of potential therapies, will most likely lead to better care of patients with COPD. Medical textbooks and clinical guidelines still largely ignore the fact that COPD seldom occurs in isolation. As the diagnosis and assessment of severity of COPD may be greatly affected by the presence of comorbid conditions, the current authors believe that lung function measurement, noninvasive assessment of cardiovascular and metabolic functions, and circulating inflammatory markers (e.g. C-reactive protein) might help to better characterise these patients. Similarly, preventive and therapeutic interventions should address the patient in their complexity.

Integrity signals

Registry

Crossref · 10.1183/09031936.00114307

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

2013 ESH/ESC Guidelines for the management of arterial hypertension
Authors Task Force Members, Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cífková, R., Backer, G. D., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,739
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,528
Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Self-citation
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,405
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234

Show all 139 references

Research works printed but not linked: 8

Fabbri LM, Rabe KF. Complexity of patients with multiple chronic diseases. Proceedings of an ERS Research Seminar (Rome, February 11–12, 2007). www.ersnet.org/ers/lr/browse/default.aspx?id_dossier = 67422 Date last accessed: October 31, 2007.
2005, Exp Lung Res, 31, 72
2007, Curr Opin Pulm Med, 13, 114
1996, Diabetes Metab, 22, 37
2000, Am J Respir Crit Care Med, 161, A583
2006, Cardiovasc Res, 3, e333
2005, Cochrane Database Syst Rev, 3, CD005374
2007, Curr Opin Pulm Med, 13, 90

Sorted by citations

Items 601–655 of 655

Método computacional de análise quantitativa da anatomia estático-torácica em imagens radiográï¬cas para estudo da doença pulmonar obstrutiva crônica
Rech, V. V., Bichinho, G. L., & Gariba, M. A. (2017) · Fisioterapia Brasil · doi:10.33233/fb.v11i3.1388
Dose response relationships of exposure and lung function of salt miners — comparative analysis of a longitudinal study with a linear and a mixed model
Lotz, G., & Kersten, N. (2012) · Zentralblatt für Arbeitsmedizin Arbeitsschutz und Ergonomie
The most frequent comorbidities at patients with the chronic obstructive pulmonary disease
Krdžić, B., Milovanović, J., Sipic, M. V., Petković, Z., & Nedeljković, B. M. (2017) · Praxis medica · doi:10.5937/pramed1804047k
Développement du score GLORI-COPD : repérer les patients atteints de bronchopneumopathie chronique obstructive à risque de complications
Eap, D., Ghasarossian, C., & Malmartel, A. (2019) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2019.02.006
Musculoskeletal disorders in patients with chronic obstructive pulmonary disease
Suleymanova, A., & Baranova, I. A. (2019) · PULMONOLOGIYA · doi:10.18093/0869-0189-2019-29-1-94-105 · Cited by 2
“ОП является одним из основных коморбидных состояний у больных ХОБЛ [5], которое часто недооценивается, но приводит к еще большему ухудшению КЖ и неблагоприятным прогнозам.”
Chronic Obstructive Pulmonary Disease (COPD) Nocturnal Desaturator patients associated with Obesity and Lung Microbiota Dynamics.
Toraldo, D. M., Nuccio, F. D., Conte, L., & Benedetto, M. D. (2018) · Università del Salento · doi:10.1285/i25327518v2i1p37
“(L M Fabbri et al. 2008, 204–12; Broekhuizen et al. 2006, 17–22) As a point of interest, it should be noted that systemic inflammation has failed, so far, to show substantial correlations with airway obstruction, (de Torres et al. 2006, 902–7; Watz et al. 2009, 1039–46) whereas a connection has…”
Background
Features of Functional Indicators in Chronic Obstructive Pulmonary Disease Patients with Obesity
Кузнецова, Л. Ф., & Gopko, О. (2019) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs04.04.014
Adherence to prescribed medication and its association with quality of life among COPD patients treated at a tertiary care hospital in Puducherry – a cross sectional study
S, S. K. K., Maharani, B., Babu, R. V., & Prakash, M. (2019) · Southwest Journal of Pulmonary and Critical Care · doi:10.13175/swjpcc021-19
SUBCLINICAL CARDIAC DAMAGE IN CARDIOPULMONARY POLYMORBIDITY
Ащеулова, Т. В., Амбросова, Т. М., Kochubiei, O., Honchar, O., & Sytina, I. V. (2019) · Inter Collegas · doi:10.35339/ic.6.2.68-76
CLINICAL PROFILE AND OUTCOME OF PATIENTS WITH HYPERCAPNIC RESPIRATORY FAILURE DUE TO ACUTE EXACERBATION OF COPD
Agrawal, M. K., Kumar, A., Agarwal, R., Agrawal, R., & Sood, S. (2019) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2019/529
The frequent exacerbator phenotype of Chronic Obstructive Pulmonary Disease in pulmonary rehabilitation – assessment of clinical outcomes and inflammation
Jenkins, A. R. (2019) · Lincoln Repository (University of Lincoln) · doi:10.24385/lincoln.24326113
Incidence of Left Ventricular Diastolic Dysfunction in Chronic Obstructive Pulmonary Disease
Jacob, M. G., & Chelakkat, M. (2020) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2020/10
Digital Health for Enhanced Understanding and Management of Chronic Conditions: COPD as a Use Case
Roca, J., Tényi, Á., & Cano, I. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11690-3
A cross sectional study of Mets in patients with COPD
Banday, S., & Gupta, D. M. (2020) · International Journal of Advanced Research in Medicine · doi:10.22271/27069567.2020.v2.i1a.36
“There are a number of studies showing that smoking is not only responsible for lung function impairment but can also lead to systemic inflammation thus contributing to systemic manifestation of COPD including MetS [29, 45] .”
The Development and Validation of a Novel Anxiety Scale to Measure and Screen Anxiety in Patients with COPD
Willgoss, T. G. (2026) · e-space (Manchester Metropolitan University) · doi:10.83056/mmu.32477694
C-reactive protein levels, airflow obstruction, and chronic kidney disease
Omori, Y., Ogata, S. M. O., & Katoh, H. A. (2012)
Association Between Metabolic Syndrome and Lung Function in Rural Areas in ChinaPreprint
Wang, F., Tian, D., Zhao, Y., Li, J., Chen, X., & Zhang, Y. (2020) · Research Square · doi:10.21203/rs.3.rs-46713/v1
“The diagnosis of COPD considering its in ammatory nature and comorbidity adds to the term chronic systemic in ammatory syndrome [5, 6].”
Background
Патогенетические основы формирования тромбофилических состояний у пациентов хронической обструктивной болезнью легких
Abduganieva, E., & Ливерко, И. В. (2021) · Общество и инновации · doi:10.47689/2181-1415-vol2-iss3-pp133-140
COPD 진료지침 2012 개정(축약본)
유지홍 (2013)
Predictors and outcomes of obstructive sleep apnea in patients with chronic obstructive pulmonary disease in China: a cross-sectional studyPreprint
Zhang, P., Chen, B., Lou, H., Zhu, Y., Chen, P., Dong, Z., Zhu, X., Li, T., & Lou, P. (2021) · Research Square · doi:10.21203/rs.3.rs-312327/v1
Tongxinluo Boosts the Effect of Atorvastatin in Treatment of Atherosclerosis With COPD by Maintaining the Pulmonary Microvascular BarrierPreprint
Kuang, X., Wang, Y., Chang, L., Yin, Y., Li, Z., Liu, Y., Li, W., Hou, Y., Wang, H., Liang, J., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-789557/v1
Pattern of co-morbidities in patients of chronic obstructive pulmonary disease
Verma, A., Singh, D., Anand, S., Kumar, A., Kumar, S., & Pandey, A. K. (2021) · The Journal of Association of Chest Physicians · doi:10.4103/jacp.jacp_49_20
AGT M235T Polymorphism and Arterial Hypertension in Patients with Chronic Obstructive Pulmonary Disease
Марущак, М. І., Maksiv, K., & Krynytska, I. Y. (2021) · Bangladesh Medical Research Council Bulletin · doi:10.3329/bmrcb.v46i3.52252
4. Complication
Teramoto, S., Yamamoto, H., Yamaguchi, Y., & Ishii, M. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.1192
The assessment of new drugs for asthma and COPD: a Delphi study examining the perspectives of Italian payers and clinicians
Sommariva, S., Finch, A. P., & Jommi, C. (2016) · Multidisciplinary Respiratory Medicine · doi:10.4081/mrm.2016.262
Comorbidities in Patients With Chronic Obstructive Pulmonary Disease
Divo, M. J., & Celli, B. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00148-7
Pulmonary Rehabilitation
Celli, B. R., & ZuWallack, R. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-4710-0.00094-8
WITHDRAWN: Correlation between cardiorespiratory coupling and six-minute walking tests in patients with chronic obstructive pulmonary diseasePreprint
Huang, Y., Lin, T., Wu, H., Chang, P., Lo, C., Wang, T., Kuo, C. S., Lin, S., Chung, F., Lin, H., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-18112/v1
Calidad de vida y salud mental en EPOC por biomasa y tabaquismo con COVID-19
Montiel-López, F., Hernández-Zenteno, R. D. J., Cassou-Martínez, M., Hernández‐Pérez, A., & Ramírez‐Venegas, A. (2022) · Respirar · doi:10.55720/respirar.14.2.3
Correlation of COPD and Metabolic syndrome and role of serum CRP level as a marker of systemic inflammation
Meher, B. K., Meher, S., Patra, G., Dhone, P. G., & Rai, N. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns6.10831
Association between Oral Health and Airflow Limitation: Analysis Using a Nationwide DatabasePreprint
Kim, S., Ku, S., Kim, J.-A., Im, Y., Cho, J. Y., Kang, H., Shin, Y. M., Kim, E., Lee, K. M., Choe, K. H., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4201218
Editorial: Chronic inflammation, oxidative stress and lipoprotein metabolism in cardio-pulmonary continuum
Sorokin, A. V., Arnardottir, H. H., Kotani, K., & Silbernagel, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1055370
“Indeed, chronic obstructive pulmonary disease (COPD), a common respiratory condition, represents the third leading cause of death worldwide (4) and epidemiological studies have shown a high prevalence of CVD comorbidities in COPD patients (5).”
Background
Prevalence and Associated Factors of COPD among Hypertensive Patients aged 40 Years or Older in China, 2014 -15Preprint
Zhao, Y., Fang, L., Wang, Z., Fan, J., Cong, S., & Wu, J. (2022) · Research Square · doi:10.21203/rs.3.rs-2329523/v1
The impact of body composition disorders on the quality of life of patients with chronic obstructive pulmonary disease
Dorosz, M., Bogacz, K., Gołdyn-Pastuszka, M., Krajczy, M., Szczegielniak, A. R., Łuniewski, J., & Szczegielniak, J. (2022) · doi:10.56984/8zg20axt7
Analysis of Correlative Factors and Intervention Measures in COPD Patients Complicated with Cognitive Impairment
周, 婷. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1351219
Noninvasive Mechanical Ventilation in COPD Exacerbations
Appendini, L. (2023) · Springer eBooks · doi:10.1007/978-3-031-28963-7_32
La nutrición como parte del manejo integral del paciente con enfermedad pulmonar obstructiva crónica: revisión narrativa
Franco, C. E. A. (2023) · Medicina · doi:10.56050/01205498.2231
Decline of the chronic respiratory disease mortality in the WHO Western Pacific Region
Khaltaev, N., & Axelrod, S. (2023) · Journal of Thoracic Disease · doi:10.21037/jtd-22-1466
“Since arterial hypertension is the most frequently occurring comorbidity in COPD optimal blood pressure control is vital for better prognosis of these patients (36).”
Combination of quantitative computed tomography and blood biochemistry for evaluating bone mineral density in a health checkup population with radiographic emphysema
Xie, S., Tang, W., Hong, W., Yang, Y., Zhu, L., Zha, X., & Zhou, Y. (2024) · Chinese Journal of Academic Radiology · doi:10.1007/s42058-024-00170-z
Comorbidity Patterns and Healthcare Resource Utilization in COPD Patients: A Retrospective Analysis Using Association RulesPreprint
Cheng, Z., Zhang, R., Xu, H., Huang, J., Liang, Z., & Yan, P. (2024) · Research Square · doi:10.21203/rs.3.rs-4901646/v1
Comorbidities of Chronic Obstructive Pulmonary Disease – An Observational Case–Control Study
Mohan, N., Kandekath, M., Nair, M. R., & Parappil, R. (2024) · PULMON · doi:10.4103/pulmon.pulmon_24_24
Guía de Práctica Clínica Mexicana de EPOC 2025
Vázquez-García, J. C., Hernández-Zenteno, R. D. J., Arroyo‐Hernández, M., Ríos, A. E., Casillas‐Suárez, C., Cortés-Telles, A., Pérez-Padilla, J. R., Sandoval‐Gutiérrez, J. L., Vázquez-Cortés, J. J., Thirión-Romero, I. I., et al. (2025) · NCT Neumología y Cirugía de Tórax · doi:10.35366/119442 · Cited by 1
Chronic obstructive pulmonary disease and comorbidity: possible implications in the disease management
Paggiaro, P., Costa, F., Malagrinò, L., & Vagaggini, B. (2011) · Reviews in Health Care · doi:10.7175/rhc.v2i1.21
Neutrophil migration and inflammation in chronic obstructive pulmonary disease
Stockley, J. A. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Mécanisme d'action d'une nouvelle molécule E008 sur les flux métaboliques hépatiques et l'oxydation phosphorylante mitochondriale
Borel, A. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Additional file 1 of Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease
Divo, M. J., Marin, J. M., Casanova, C., Cabrera Lopez, C., Pinto-Plata, V., Marín‐Oto, M., Polverino, F., de-Torres, J. P., Billheimer, D., & Celli, B. R. (2022) · Figshare · doi:10.6084/m9.figshare.21220045
Additional file 1 of Impact of comorbidities in COPD clinical control criteria. The CLAVE study
Almagro, P., Soler-Cataluña, J. J., Huerta, A. H., Alsina, D. G.-S., & Cosío, B. G. (2024) · Figshare · doi:10.6084/m9.figshare.26658184
Additional file 2 of Impact of comorbidities in COPD clinical control criteria. The CLAVE study
Almagro, P., Soler-Cataluña, J. J., Huerta, A. H., Alsina, D. G.-S., & Cosío, B. G. (2024) · Figshare · doi:10.6084/m9.figshare.26658187
Sextual Dysfunction and Quality of Life in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta AnalysisPreprint
Rahman, M. A., Rana, M. M., Selim, S., Ferdousi, K. R., Majumder, S., & Chakrabortty, R. (2026) · Research Square · doi:10.21203/rs.3.rs-8813265/v1
THE METHOD OF IDENTIFYING THE INCREASED RISK GROUPS FOR THE DEVELOPMENT OF STROKES, MYOCARDIAL INFARCTIONS AND LETHAL OUTCOMES DURING 5 YEARS IN PATIENTS WITH ARTERIAL HYPERTENSION OF THE 2ND DEGREE COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Kozlovsky, V. I. (2023) · Vestnik of Vitebsk State Medical University · doi:10.22263/2312-4156.2023.6.25
Preoperative Lung Function Assessment and the Impact of Spirometry Misdiagnosis on Mortality Following Cardiac Surgery
Peat, R., FitzMaurice, T. S., Frost, F. J., Shaw, M., Kirmani, B. H., & Mayhew, D. (2026) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2026.05.042
Muscle-lung crosstalk in COPD: how exercise training modulates protein metabolism and inflammation in experimental COPD models
Abbasi, A., Vieira, R. P., & Lopes, F. D. T. Q. S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1870091
“The concept of COPD as a systemic disease is further supported by the frequent coexistence of systemic in ﬂ ammation and multiple extrapulmonary manifestations (4).”
Chronic Obstructive Pulmonary Disease in Heart Failure with Reduced Ejection Fraction: Prevalence, Prognostic, and Association of Triple Inhaled Therapy
Aguayo-Caño, N., Torres-Zamudio, J. A., Armijo, J. P., Martin-Diaz, J. D., Yacub-Briceño, N., Cabello-Terron, M., Enrile-Sanchez, E., Roldán-Guerra, Á., Manzanares, R. G., Crespín-Crespín, M., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15218439
Chronic obstructive pulmonary disease, pulmonary function and cardiovascular disease
McAllister, D. A. (2011) · ERA
Estudo da remodelação cardíaca em pacientes com doença pulmonar obstrutiva crônica
Coleta, K. D. (2010) · doi:10.5016/dt000613648

Authors: Fabbri, L. M., Luppi, F., Beghé, B., & Rabe, K. F.
Affiliations: University of Modena and Reggio Emilia (IT)
ORCID: Fabbri, L. M.
Luppi, F.
Beghé, B.
Rabe, K. F.
Venue: European Respiratory Journal
Publisher: European Respiratory Society (ERS)
Published: 2007-12-31
Volume: 31
Issue: 1
Pages: 204-212
ISSN: 0903-1936 (ISSN-L)
1399-3003
DOI: 10.1183/09031936.00114307
OpenAlex: W2165340553
Cited by: 660
References: 139
Citations by year: 2026: 8 · 2025: 16 · 2024: 20 · 2023: 17 · 2022: 26 · 2021: 19 · 2020: 35 · 2019: 25 · 2018: 36 · 2017: 48 · 2016: 31 · 2015: 50 · 2014: 68 · 2013: 55 · 2012: 59
FWCI: 28.24
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: cc-by
Locations: European Respiratory Journal (publishedVersion)
PubMed (publishedVersion)
BOA (University of Milano-Bicocca) (submittedVersion)
IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Keywords: chronic obstructive pulmonary disease, comorbidities, systemic inflammation, chronic heart failure, metabolic syndrome, cigarette smoking, C-reactive protein, inflammatory markers, COPD severity assessment, cardiovascular function, COPD management
MeSH terms: Chronic Disease, Health Status, Humans, Inflammation, Lung, Models, Biological, Prognosis, Risk Factors, Smoking, Pulmonary Medicine, Comorbidity, Guidelines as Topic, Pulmonary Disease, Chronic Obstructive, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Complex chronic comorbidities of COPD

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks